Syed K. Fareed

Sarah J. Fischer

William G. Gaede, III

Mandy H. Kim

Samoneh Kadivar

Christian J. Hurt

Jennifer L. Truelove

Nicholas Matich

Saif Askar

Jamie Levien

Alnylam Pharmaceuticals Inc

Board of Regents of University of Texas System

Last Docket Entry Date

Total Docket Entries

Prior evaluation alleged: U. of Texas hits Alnylam, claiming its $1.3B+ Onpattro drug uses patented siRNA tech with `neutral charge` lipid compositions.

1:24-cv-01524 | Board Of Regents Of University Of Texas System v. Alnylam Pharmaceuticals Inc | Ex Parte

United States Western District of Texas

Name	Ratings
McKool Smith	L5E
Jennifer L. Truelove	L5D
Christian J. Hurt	L5E
Jamie Levien	L1D
Nicholas Matich	---- --
Saif Askar	---- --

Name	Ratings
McDermott Will & Emery LLP	L5D
Syed K. Fareed	L5A
William G. Gaede, III	L5A
Sarah J. Fischer	L5B
Mandy H. Kim	L5E
Samoneh Kadivar	L3C

1:24-cv-01524

Board Of Regents Of University Of Texas System v. Alnylam Pharma Inc